| Literature DB >> 32433505 |
Alexander Wyckman1, Islam Abdelrahman2,3, Ingrid Steinvall2, Johann Zdolsek2, Hans Granfeldt4, Folke Sjöberg2, Hans Nettelblad2, Moustafa Elmasry2.
Abstract
BACKGROUND: The pectoralis major flap, which is usually harvested bilaterally, is considered a workhorse flap in the reconstruction of sternal defects. After a median sternotomy for open heart surgery, 1%-3% of patients develop deep infection and dehiscence of the sternal wound, some of which will eventually require reconstructive surgery. Our aim was to describe the clinical feasibility and associated complications of the unilateral pectoralis major advancement flap in the reconstruction of sternal defects.Entities:
Mesh:
Year: 2020 PMID: 32433505 PMCID: PMC7239941 DOI: 10.1038/s41598-020-65398-y
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Flowchart showing the selection of patients. ZZR30 is the ICD-10-SE procedure code for “reconstruction with a muscle flap”. A total of 45 reconstructions of sternal defects were done with muscle flap, 43 with a unilateral pectoralis muscle flap, one with bilateral pectoralis muscle flaps and one with another muscle flap.
Figure 2Flowchart showing different times of admissions for patients who had open heart surgery and were later readmitted for revision surgery, treatment using negative wound pressure, and antibiotics, when they developed signs of sternal instability or sternal infection, or both. If reconstructive surgery was indicated, the necessary flap was revised. The last visit, when the antibiotic treatment could be ended, was classed as the end point for healing of the defect. NPWT = negative pressure wound therapy.
Figure 3(A) Sternal wound with deep infection after cardiac surgery. (B). Sternal wound after debridement. (C) The left pectoralis major muscle being mobilized after dissection. (D) The pectoral flap sutured in place to cover the defect. (E) After skin closure.
Figure 4A set of special long surgical instruments: long retractor, bipolar diathermy forceps, tweezers, straight and curved scissors.
Description of the patients.
| Number of patients | 43 |
| Age (at flap surgery) | 76.2 (69.4–80.1) |
| BMI | 27.9 (24.8–31.4) |
| Co-existing medical conditions | |
| Cardiovascular disease | 41 (95) |
| Diabetes | 13 (30) |
| Malignancy | 7 (16) |
| Renal failure | 4 (9) |
| Corticosteroid treatment | 7 (16) |
| Chronic obstructive pulmonary disease | 5 (12) |
| Other diagnoses | 22 (51) |
| Smokers | 4 (9) |
| Former smokers | 14 (33) |
| Non-smokers | 25 (58) |
| Operation time, minutes | 113 (86–139) |
| Anaesthesia time, minutes | 165 (140–195) |
| Duration of stay for flap surgery, days | 12.4 (7.3–18.0) |
| Total duration of stay, daysa | 39.0 (30.0–50.0) |
| Time between thoracic surgery and flap surgery, days | 35.6 (21.7–50.4) |
| Mortality during hospital stay | 3 (7) |
| Left-sided pectoralis major flap | 38 (88) |
| Female sex | 14 (33) |
Data are presented as median (25–75 centile) or n (%).
aDuration of stay during thoracic surgery and flap surgery.
The difference between the patients grouped by flap outcome.
| Flap failure (n = 3) | Flap success (n = 37) | P-values | |
|---|---|---|---|
| Patient factors | |||
| Age (at flap surgery) | 78.6 (76.2–83.5) | 74.4 (68.2–80.1) | 0.32 |
| BMI | 31.1 (28.1–38.9) | 27.8 (24.6–31.4) | 0.18 |
| Female sex | 0 | 12 | 0.54 |
| Pre-existing medical conditions | |||
| Diabetes | 1 | 10 | 1.00 |
| Smoking | 3 (100) | 15 (41) | 0.08 |
| COPD | 0 | 5 | 1.00 |
| Cardiovascular disease | 3 | 35 | 1.00 |
| Corticosteroid treatment | 1 | 6 | 0.45 |
| Other | 3 | 17 | 0.23 |
| Malignancy | 0 | 7 | 1.00 |
| Renal failure | 0 | 2 | 1.00 |
| Number of patients with complications | 3 | 16 | 0.10 |
| Number of patients with complications not requiring surgery | 0 | 7 | 1.00 |
| Types of complications not requiring surgery | |||
| Seroma or hematoma | 0 | 7 | 1.00 |
| Fistulation | 0 | 1 | 1.00 |
| Number of patients with complications requiring surgery | 3 | 9 | 0.02 |
| Types of complications requiring surgery | |||
| Post-operative bleeding | 2 | 7 | 0.12 |
| Signs of persistent infection | 1 | 3 | 0.28 |
| Wound dehiscence | 0 | 3 | 1.00 |
| Fistulation | 0 | 2 | 1.00 |
| Skin necrosis | 2 | 0 | 0.04 |
| Flap detachment | 1 | 0 | 0.08 |
| Patients reporting pain/discomfort in flap area at follow-up visits | 0 | 9 | 1.00 |
| Duration of stay (flap) | 31 (15.6–89.3) | 11.4 (7.3–16.6) | 0.02 |
| Total duration of stay | 50 (48–122) | 38 (30–47) | 0.048 |
| Operation time | 150 (75–155) | 110 (86–135) | 0.46 |
| Anaesthesia time | 210 (115–235) | 163 (140–195) | 0.29 |
Data are presented as median (25–75 centile) or n.
Flap outcome and complications.
| Viable flapa | 37 (93) |
| Non-viable flapa | 3 (8) |
| Healing timeb | 47.4 (27.6–60.6) |
| Number of patients with complications | 21 (49) |
| Number of patients with complications not requiring surgery | 8 (19) |
| Types of complications not requiring surgery | |
| Seroma or hematoma | 8 |
| Fistulation | 1 |
| Number of patients with complications requiring surgery | 13 (30) |
| Types of complications requiring surgeryc | |
| Post-operative bleeding | 10 |
| Signs of persistent infection | 4 |
| Wound dehiscence | 3 |
| Fistulation | 2 |
| Skin necrosis | 2 |
| Flap detachment | 1 |
| Patients reporting pain/discomfort in flap area at follow-up visits | 9 |
aThe calculation of percentage is done by using 40 patients as three patients died within 30 days of the flap surgery.
bThe time between flap surgery and the last day of antibiotic treatment, calculated on the group with viable flaps.
cOne patient could have several complications contributing to the decision of re-operation.
Logistic regression for flap loss and complications.
| Coefficient | p | 95% CI | |
|---|---|---|---|
| Age, years | 0.25 | 0.04 | 0.02 to 0.49 |
| Body mass index | −0.17 | 0.20 | −0.43 to 0.09 |
| Female sex, male is reference | −8.80 | 0.02 | −16.17 to −1.43 |
| Number of revisions/ NPWT dressing changes | −2.39 | 0.04 | −4.64 to −0.15 |
| Total number of different antibiotics | 1.95 | 0.03 | 0.20 to 3.69 |
| NPWT-treatment prior to flap surgery, days | 0.79 | 0.04 | 0.05 to 1.53 |
| Constant | −18.93 | 0.07 | −39.51 to 1.64 |
Multivariable logistic regression pseudo R2 0.58, Model p < 0.001, n = 41. Flap loss and complications (n = 21) are coded as 1. Flap success with no complications are coded as 0. NPWT = Negative pressure wound therapy.
Linear regression for healing time.
| Coefficient | p | 95% CI | |
|---|---|---|---|
| Re-operation, thorax | 46.00 | 0.003 | 17.17 to 74.77 |
| Flap loss and complications, presence | 33.38 | <0.001 | 16.03 to 50.73 |
| Female sex, male is reference | 5.16 | 0.59 | −14.37 to 24.70 |
| Body mass index | 1.28 | 0.19 | −0.67 to 3.23 |
| Age, years | −0.52 | 0.24 | −1.41 to 0.37 |
| Constant | 29.69 | 0.50 | −59.19 to 118.56 |
Multivariable linear regression R2 0.54, model p < 0.001, n = 35.